Vitamin D Therapy Market Outlook 2027
Vitamin D therapy is one of many vitamins, which helpsto in the development and calcification of the bones. Adequate exposure to sunlight and the use of dairy products with vitamin D have significantly reduced the incidence of vitamin D deficiency. However, vitamin D deficiency is still a common problem among the population, particularly in older adults. It helps to absorb dietary calcium and phosphorus from the intestines. Furthermore, it suppresses the release of parathyroid hormone, a hormone that causes bone resorption. The major reasons for low levels of vitamin D are lack of vitamin D in the diet, often in conjunction with inadequate sun exposure, inability to absorb vitamin D from the intestines, and inability to process vitamin D due to kidney or liver disease.
COVID-19 scenarioanalysis
Pharmaceutical and biotechnological companies together with governments around the globe are working to combat with the COVID-19 outbreak, from supporting the development of vaccines to schedule for medicines supply chain challenges. Furthermore, there are around 115 vaccine candidates and other 155 molecules that are kept in the R&D pipeline in the coming years. Moreover, commonly used drugs such as hydroxychloroquine have seen huge boost in demand for the management of COVID-19. Increase in demand for drugs has been witnessed, which is likely to offer lucrative opportunity for manufacturers of COVID-19 management drugs, as many developed countries are short of these drugs. Owing to the demand for vaccine and treatment drugs for COVID-19, the pharmaceutical and biotechnology industry is anticipated to witness a substantial growth in the next few years.
Top impacting factors:market scenario analysis, trends, drivers, and impact analysis
The major factor affecting the industry include increase in awareness regarding vitamin D deficiencies. Furthermore, the presence of a larger patient population is expected to propelthe market growth in the next few years.In addition, increase in the healthcare expenditure would help the industry grow during the forecast period.Presence of people suffering from undernutrition further propelsthe market growth. However, the unfavorable reimbursement scenario may hinder the growth of the industry.
Increase in research and development of vitamin D therapy market
Rise in the research and development which would increase the applications of the vitaminD therapy is anticipated to help the market to gain traction in the next few years. For instance, in October 2020, Researchers from Queen Mary University of London, funded by Barts Charity, have launched a new clinical trial to investigate whether taking vitamin D could protect people from COVID-19. CORONAVIT will run for six months and involve more than 5,000 people to find out whether a test-and-treat approach to cure vitamin D deficiency during winter will reduce the risk and/or severity of COVID-19 and other acute respiratory infections.
People will take part in the study from their homes, without any face-to-face visits needed, as all vitamin D tests and supplements will be sent via the post. UK residents aged 16 or more can participate if they are not already taking high-dose vitamin D. To register interest, people can contact the study team. Strategies to boost the UK population's immunity to respiratory infections propels the need for vitamin D therapy, asthedevelopment of an effective vaccine for coronavirus is pending.
Surge in number of mergers and acquisitions
Increase in the number of mergers and acquisitions is anticipated toboost the industrygrowth in the coming years. For instance, in February 2020, bioavailability of water insoluble compounds such as CBD enhanced up to 15 times with the technology of Solmic, which would help to its acquisition by Betterlife. A producer of pharmaceutical grade products, Betterlife announced the acquisition of Swiss-based Solmic, aiming to tap into the latter’s formulation technology suitable for orallydelivered Cannabidiol-based (CBD) products.
Solmic’s technology is based on the production of stable micelles containing water-soluble ingredients by as much as 15 times, allowing accelerated uptake of the ingredients in the human digestive tract according to Betterlife.
Key benefits of the report:
- This study presents the analytical depiction of the global vitamin D therapy market along with the current trends and future estimations to determine the imminent investment pockets.
- The report presents information related to key drivers, restraints, and opportunities along with detailed analysis of the global vitamin D therapy market share.
- The current market is quantitatively analyzed to highlight the vitamin D therapy market growth scenario.
- Porter’s five forces analysis illustrates the potency of buyers & suppliers in the market.
- The report provides a detailed vitamin D therapy market analysis depending on competitive intensity and how the competition will take shape in coming years.
Questions answered in the global vitamin D therapy market research report:
- Which are the leading players active in the global vitamin D therapy market?
- What are the current trends that will influence the market in the next few years?
- What are the driving factors, restraints, and opportunities of the market?
- What are the projections for the future that would help in tasking further strategic steps?
Vitamin D Therapy Market Report Highlights
| Aspects | Details |
 By Route of Administration |
|
 By Purchase Pattern |
|
 By Application |
|
 By Region |
|
 Key Market Players | Cadila Healthcare Ltd.,, Merck & Co., Inc.,, Zhejiang Garden Biochemical High-tech, GlaxoSmithKline, Sun Pharmaceutical Industries Ltd., Abbott,, Pfizer, Inc.,, Sanofi,, Novartis International AG,, Torrent Pharmaceuticals Ltd., |
Loading Table Of Content...
